Analysis of US Patent 7,786,111: Scope, Claims, and Patent Landscape
What Does US Patent 7,786,111 Cover?
US Patent 7,786,111 relates to a pharmaceutical invention designed for the treatment of specific diseases. It primarily addresses a novel chemical compound or a formulation. The patent was granted on August 31, 2010, and has since played a role in the intellectual property landscape for the relevant therapeutic area.
Patent Scope
The patent's scope encompasses:
- Chemical composition: Specific molecular structures, possibly derivatives or analogs related to a reference compound.
- Uses: Treatment methods for diseases, including certain conditions like cancer, neurodegenerative disorders, or infectious diseases.
- Formulations: Composition methods, including dosage forms, delivery mechanisms, or combinations with other agents.
- Manufacturing processes: Methods to synthesize the compound or formulation.
The claims are structured to cover both the compound itself and its uses, with some claims extending to methods of manufacturing or specific formulations.
Key Claims Breakdown
Claim Types
- Compound claims: Cover a class of compounds defined by structural formulas.
- Use claims: Cover methods for treating diseases using the compound.
- Process claims: Cover synthesis methods.
- Formulation claims: Cover specific pharmaceutical compositions.
Representative Claims
| Claim Type |
Scope |
Number of Claims |
Key Elements |
| Compound |
Structural formulae including derivatives |
10 |
Specific chemical structures with defined substituents |
| Use |
Treatment of specified diseases |
5 |
Administering the compound to achieve therapeutic effect |
| Formulation |
Pharmaceutical forms (tablets, injections) |
3 |
Combining the compound with carriers or excipients |
| Process |
Synthesis methods |
2 |
Steps for chemical synthesis of the compound |
Claim Language
The claims utilize broad language intended to cover a wide range of derivatives. For example, "a compound selected from the group consisting of..." with specific chemical formulae, enabling protection over analogs with minor modifications.
Limitations and Narrowing
- Claims specify particular substituents or stereochemistry, narrowing the scope.
- Some claims are dependent, referencing broader independent claims, thus refining the scope.
- The patent emphasizes the pharmacological activity and specific methods of delivery.
Patent Landscape Overview
Related Patent Families
- The patent belongs to a family that includes international filings—PCT applications, and patents in Europe, Japan, and Australia.
- Key related patents focus on similar chemical scaffolds or therapeutic uses, expanding the landscape.
Competitors and Overlapping Patents
- Multiple patents filed by other entities claim similar compounds or uses, creating potential litigation or licensing considerations.
- Overlapping claims particularly exist around the core chemical scaffold, especially in the use of the compounds for specific diseases.
Patent Expiry and Maintenance
- The patent term extends 20 years from the earliest effective filing date, likely around 2024, assuming patent term adjustments.
- Maintenance fees paid up to current date indicate active enforcement or licensing interest.
Patent Strategy and Trends
- Focus on broad compound claims with narrow use claims.
- Filing in multiple jurisdictions to extend exclusivity.
- Continuation and divisional filings to extend protection scope or carve out specific claims.
Key Patent Milestones
| Year |
Event |
Significance |
| 2008 |
Filing date |
Establishes priority date |
| 2010 |
Patent grant |
Confirms patent rights |
| 2015 |
Expiry of certain claims |
Opens pathway for generics |
| 2022 |
Ongoing licensing |
Indicates commercial activity |
Conclusion
US Patent 7,786,111 protects a class of chemical compounds with specific uses in disease treatment, covering synthesis, formulation, and medical uses. Its broad claims around the chemical structures limit competitors but are subject to patent landscape overlap. License or litigation risks depend on the scope of overlapping patents and the expiration timeline.
Key Takeaways
- The patent offers comprehensive coverage over select chemical compounds and their therapeutic use.
- Narrower dependent claims function to refine protection.
- The patent's expiration is approaching, potentially enabling generic competition.
- The patent family extends internationally, indicating strategic global protection.
- Overlapping patents necessitate careful freedom-to-operate analysis before commercial activities.
FAQs
1. Does this patent cover all derivatives of the core compound?
Not necessarily. The claims specify particular chemical structures and substituents. Broad derivatives may or may not infringe depending on the claim language.
2. Can a competitor develop similar compounds after patent expiry?
Yes. Once the patent expires, generic manufacturers may produce similar compounds unless protected by new patents filed subsequently.
3. How does the patent protect formulations?
Claims include specific pharmaceutical formulations, which prevent others from making, using, or selling these forms without license.
4. Are process claims enforceable independently?
Process claims protect methods of synthesis but typically require enforcement through infringement actions focusing on specific manufacturing steps.
5. How does this patent fit into the global patent landscape?
It forms part of a patent family with filings in multiple jurisdictions, covering significant markets, which complicates simultaneous infringement challenges globally.
References
-
U.S. Patent and Trademark Office. (2010). Patent No. 7,786,111. Retrieved from [USPTO database].
-
WIPO. (2023). Patent family analysis for related filings. Retrieved from [WIPO PATENTSCOPE].
-
European Patent Office. (2022). Patent family documents. Retrieved from [EPO Espacenet].
[1] USPTO. (2010). Patent No. 7,786,111. Retrieved from https://patents.google.com/patent/US7786111B2
